News for 'Sun Pharmaceuticals'

Seminar Celebrates Acharya P C Ray's Legacy In Pharmaceutical Sciences

Seminar Celebrates Acharya P C Ray's Legacy In Pharmaceutical Sciences

Rediff.com28 Aug 2026

A seminar in New Delhi commemorated Acharya Prafulla Chandra Ray's birth anniversary, focusing on his significant contributions to pharmaceutical sciences and his vision for indigenous research and self-reliance. Organised by DPSRU and VIBHA, the event highlighted Ray's pioneering efforts in "Swadeshi science" and his role in establishing India's pharmaceutical industry.

Kanpur Murder: New Evidence Puts Son Subrat Under Police Scrutiny

Kanpur Murder: New Evidence Puts Son Subrat Under Police Scrutiny

Rediff.com6 days ago

The investigation into the murder of pharmaceutical trader Vineet Manocha has intensified, with his son Subrat now under police scrutiny. New evidence reveals that the alleged shooter made multiple calls to Subrat from a newly purchased SIM card. While Subrat's wife Shalu and two others are already arrested, police are examining call detail records and financial affairs to uncover Subrat's potential involvement in the conspiracy.

Police Seek Custody Of Daughter-In-Law In Kanpur Trader Murder Case

Police Seek Custody Of Daughter-In-Law In Kanpur Trader Murder Case

Rediff.com11 Sep 2026

Kanpur police are seeking 15 days' custody of Shalu, daughter-in-law of slain pharmaceutical trader Vineet Manocha, for intensive interrogation. Shalu is alleged to be the mastermind behind Manocha's brutal murder, having reportedly hired two men for Rs 6 lakh. Her husband, Subrat, also remains under scrutiny, with police examining call records and deleted messages to uncover the full conspiracy.

Symbiotec Pharmalab shares end over 11% higher after flat debut

Symbiotec Pharmalab shares end over 11% higher after flat debut

Rediff.com1 Sep 2026

Shares of Symbiotec Pharmalab Ltd, a pharma and biotech company, made a muted market debut, listing nearly 1 per cent lower on the BSE against its issue price of Rs 988, but later recovered to trade higher.

Putin reaches Delhi for BRICS summit, to meet Modi today

Putin reaches Delhi for BRICS summit, to meet Modi today

Rediff.com11 Sep 2026

Russian President Vladimir Putin has arrived in India for a three-day visit to attend the BRICS summit and hold bilateral talks with Prime Minister Narendra Modi, focusing on expanding trade, investment, and energy cooperation amidst global geopolitical challenges.

Kiran Bedi seeks role in Satya Niketan hostel collapse case, HC says...

Kiran Bedi seeks role in Satya Niketan hostel collapse case, HC says...

Rediff.com4 days ago

Retired IPS officer Kiran Bedi has sought to intervene in a Delhi High Court case regarding the collapse of a hostel building in Satya Niketan, which resulted in seven deaths. The court acknowledged her experience despite opposition from the Centre, Delhi government, and MCD, who were given three days to respond to her plea. The High Court had previously ordered an inquiry into the September 6 collapse, highlighting concerns about housing safety and regulatory measures.

What Will Modi-Putin Discuss?

What Will Modi-Putin Discuss?

Rediff.com11 Sep 2026

One of the important topics of discussion between the two leaders is expected to be the Northern Sea Route and the Chennai-Vladivostok Maritime Corridor.

Kiran Bedi seeks role in Satya Niketan hostel collapse case, HC says...

Kiran Bedi seeks role in Satya Niketan hostel collapse case, HC says...

Rediff.com4 days ago

Retired IPS officer Kiran Bedi on Thursday approached the Delhi high court seeking to be made a party in a matter concerning the hostel building collapse in Satya Niketan that left seven people dead, saying she wanted to bring forth "critical public domain disclosures" and the "nexus" in the operation of PG hostels.

New York Tragedy: 2 Desi Students Run Over By Train

New York Tragedy: 2 Desi Students Run Over By Train

Rediff.com6 days ago

Tragedy struck two New Jersey families with Rutgers University graduates Navam Kaul and Malaika Chitre, both 24, hit by a subway train in Manhattan.

IIT Madras Breakthrough: Chemical-Free Surface Fights Superbugs

IIT Madras Breakthrough: Chemical-Free Surface Fights Superbugs

Rediff.com6 Sep 2026

Researchers at IIT Madras have patented a chemical-free antibacterial surface that physically eliminates harmful bacteria, including "superbugs," without relying on antibiotics or disinfectants. This innovative technology uses specially engineered nanostructures to rupture bacterial cell walls, offering a sustainable solution to Antimicrobial Resistance (AMR) for biomedical and public health applications.

Lupin eyes $500 million from biosimilars, expands global footprint

Lupin eyes $500 million from biosimilars, expands global footprint

Rediff.com6 days ago

Pharma major Lupin is significantly increasing its focus on biosimilars, aiming for a turnover of nearly $500 million from this segment over the next five years, driven by new product launches and expanded presence in key global markets like the US, Europe, and Japan.

Indian Start-up Serendipity Space Achieves Drug Crystallisation In Near-Space

Indian Start-up Serendipity Space Achieves Drug Crystallisation In Near-Space

Rediff.com14 Aug 2026

Odisha-based Serendipity Space successfully demonstrated drug crystallisation processes on a satellite prototype in a near-space mission. This breakthrough aims to enable pharmaceutical manufacturing in low Earth orbit, leveraging microgravity to create superior drug crystal structures for enhanced solubility, stability, and effectiveness. The mission tested core technologies, including an autonomous pharmaceutical factory, and was inspired by advancements made on the International Space Station.

The Importance Of Veer Guardian

The Importance Of Veer Guardian

Rediff.com16 hours ago

The political confidence required to place high-end Japanese aircraft and personnel on Indian soil is itself a data point.
It indicates a level of trust that would have been difficult to imagine when India-Japan defence ties were largely symbolic, explains Varun Arya.

Revealed: What Modi said to Iranian President about war

Revealed: What Modi said to Iranian President about war

Rediff.com31 Aug 2026

Prime Minister Narendra Modi met Iranian President Masoud Pezeshkian at the SCO summit, advocating for dialogue and diplomacy to resolve the West Asia conflict and expressing India's desire to expand and diversify trade with Iran. Pezeshkian, in turn, urged India to leverage its contacts to promote peace.

Indian Equities Extend Losing Streak as Sensex Tumbles 417 Points

Indian Equities Extend Losing Streak as Sensex Tumbles 417 Points

Rediff.com3 Sep 2026

Indian benchmark equity indices extended their losing streak for a fourth consecutive day, with the Sensex tumbling 417 points due to rising crude oil prices and a significant sell-off in IT stocks, impacting overall investor sentiment.

Sensex, Nifty pare gains on mixed global cues

Sensex, Nifty pare gains on mixed global cues

Rediff.com4 Sep 2026

The benchmark BSE Sensex rebounded by 362 points, ending a four-day losing streak, driven by strong buying in metal, private banking, and oil and gas shares, while the broader NSE Nifty saw modest gains despite paring some advances in the closing session.

'Sword to kill mosquito': HC raps Maha FDA over Cadila drug action

'Sword to kill mosquito': HC raps Maha FDA over Cadila drug action

Rediff.com11 Aug 2026

The Bombay High Court has strongly criticised the Maharashtra FDA for its "shoot first" approach, likening its drastic actions to using a sword to kill a mosquito. The court, hearing a petition from Cadila Pharmaceuticals, directed the FDA to grant companies a hearing before taking severe measures, warning of heavy costs for its arbitrary conduct.

Indian drugmakers in no rush to shift to US despite tariff threat

Indian drugmakers in no rush to shift to US despite tariff threat

Rediff.com10 Aug 2026

Indian pharmaceutical companies are not rushing to relocate manufacturing to the United States despite former President Donald Trump's renewed threat of tariffs up to 200 per cent on imported generic drugs. Instead, they are leveraging existing US plants, contract manufacturers, and making selective investments in complex products while maintaining India as their primary production hub.

Stock Markets Today: Sensex, Nifty Gain on Bank Stocks, Global Cues

Stock Markets Today: Sensex, Nifty Gain on Bank Stocks, Global Cues

Rediff.com3 Sep 2026

Indian benchmark equity indices, Sensex and Nifty, rebounded in early trade after a three-day slide, driven by strong buying in blue-chip bank stocks and a firm trend in global markets, supported by easing US bond yields and record foreign-currency deposit inflows.

BRICS 2026: India's Chance To Make Diplomatic Gains

BRICS 2026: India's Chance To Make Diplomatic Gains

Rediff.com12 Sep 2026

For India, the goal is not simply to host another grand diplomatic gathering. It is to prove that a diverse coalition of emerging powers can still deliver.

The Long Road To Viksit Bharat

The Long Road To Viksit Bharat

Rediff.com6 days ago

The question for the next 20 years is not whether India can become a $5 trillion or $10 trillion economy. Those are attractive targets, but the real question is whether India can create enough productive jobs, educate its children properly, make its cities liveable, and give hundreds of millions of people a substantially better life, asserts Ramesh Menon.

India sees Rs 4,896 crore FDI in 29 projects after easing China stake norms

India sees Rs 4,896 crore FDI in 29 projects after easing China stake norms

Rediff.com22 Aug 2026

India has attracted foreign direct investment (FDI) worth approximately 4,896 crore across 29 projects since May, following the government's relaxation of norms under Press Note 2 of 2026. The revised rules permit investment without government approval from entities with up to 10 per cent non-controlling ownership by land-bordering countries.

7 AI-Linked Courses To Boost Your Career

7 AI-Linked Courses To Boost Your Career

Rediff.com8 Sep 2026

Students are learning to combine technology with agriculture, healthcare, biotechnology, architecture and fashion, explains Mandeep Singh, assistant professor and deputy dean, Lovely Professional University.

Rs 1 Trillion Club Swells

Rs 1 Trillion Club Swells

Rediff.com2 Sep 2026

Newly listed companies Vedanta Aluminium Metal, SBI Funds Management and Manipal Health Enterprises have entered the Rs 1 trillion mcap list since March 2026.

India ready to help end Russia-Ukraine war, Jaishankar says in Kyiv

India ready to help end Russia-Ukraine war, Jaishankar says in Kyiv

Rediff.com3 Sep 2026

External Affairs Minister S Jaishankar visited Kyiv, reiterating India's readiness to assist in ending the Ukraine-Russia war. He emphasised that solutions would not emerge from the battlefield and highlighted Prime Minister Modi's call for an end to the conflict. Discussions also covered humanitarian aid, the impact on commercial shipping, and bilateral trade, with Jaishankar inviting his Ukrainian counterpart to India for further talks.

'India And China Have Arrived At A Nash Equilibrium'

'India And China Have Arrived At A Nash Equilibrium'

Rediff.com12 Sep 2026

'The Chinese military cannot advance much in Ladakh, even if they want to.' 'Similarly, in Arunachal Pradesh, they can rename a village or two, intrude here or there, but cannot do much more realistically.'

Industry credit growth jumps 20% in July, gold loans moderate: RBI data

Industry credit growth jumps 20% in July, gold loans moderate: RBI data

Rediff.com1 Sep 2026

Bank credit to industry in India surged by 20 per cent year-on-year in July, significantly accelerating from the previous year, driven by strong expansion in sectors like engineering, gems and jewellery, and petroleum-related industries, according to the Reserve Bank of India (RBI). However, growth in gold loans, while still expanding, saw a sharp moderation.

Why Foreign Investors Are Missing India's Real Story

Why Foreign Investors Are Missing India's Real Story

Rediff.com2 Sep 2026

If India does get $100 billion a year in FDI, it would be a game-changer in every possible way. FPIs would come rushing back, AI or no AI, points out Debashis Basu.

Sun Pharma sees 27% profit surge in Q1FY27, driven by India and innovative medicines

Sun Pharma sees 27% profit surge in Q1FY27, driven by India and innovative medicines

Rediff.com1 Aug 2026

Sun Pharmaceutical Industries reported a 27 per cent year-on-year increase in consolidated net profit to 2,894.7 crore for Q1FY27, with revenue growing 10 per cent to 15,299.8 crore, driven by strong performance in India and innovative medicines.

Putin Offers More Fertilisers To India

Putin Offers More Fertilisers To India

Rediff.com25 Aug 2026

Russia remains India's biggest fertiliser supplier, with imports rising nearly 40 per cent in 2025.

0%, 100%, 200%: Trump's new generic drug tariff may hit India

0%, 100%, 200%: Trump's new generic drug tariff may hit India

Rediff.com22 Jul 2026

US President Donald Trump announced steep tariffs on imported generic medicines, effective from August 2028, with the aim of boosting domestic pharmaceutical production. This policy, which includes a phased increase in tariffs up to 200 per cent, could significantly impact India, a major global supplier of generic drugs to the US market.

11-year-old rape survivor delivers baby girl in Haryana hospital

11-year-old rape survivor delivers baby girl in Haryana hospital

Rediff.com29 Jul 2026

An 11-year-old rape survivor in Yamunanagar, Haryana, has given birth to a baby girl at the District Civil Hospital. Both the mother and baby are in stable condition. The minor's pregnancy was discovered in May, leading to the arrest of the accused under the POCSO Act. The family has consented to hand over the newborn to the Child Welfare Committee.

MutAIverse: AI Breakthrough In Decoding Cancer's Origins

MutAIverse: AI Breakthrough In Decoding Cancer's Origins

Rediff.com20 Aug 2026

Researchers at Delhi's Indraprastha Institute of Information Technology have developed 'MutAIverse', a generative AI platform designed to decode DNA damage and identify potential causes of cancer. Tested on head and neck cancer patients in Guwahati, the platform successfully traced exposure to smokeless tobacco as a contributing factor. This innovation aims to shift focus from just diagnosis to understanding causative factors, potentially aiding in prevention and protection.

Sensex, Nifty tank nearly 1% as crude oil prices surge and bank stocks face selling pressure

Sensex, Nifty tank nearly 1% as crude oil prices surge and bank stocks face selling pressure

Rediff.com22 Jul 2026

Indian benchmark indices Sensex and Nifty tumbled nearly 1 per cent for the third consecutive day, driven by a sharp spike in crude oil prices and significant selling in bank stocks, with Brent crude jumping to USD 95.27 per barrel.

Alzheimer's Can't Be Cured, But Delayed

Alzheimer's Can't Be Cured, But Delayed

Rediff.com21 Aug 2026

'Think of the brain like a machine, and Alzheimer's is like rust.'
'Like a rusty machine breaks down, a rusty brain also breaks down. And when it breaks down, you have memory loss, cognitive issues and so on.'

Parliamentary Panel Pushes for Swift India-US Bilateral Trade Agreement

Parliamentary Panel Pushes for Swift India-US Bilateral Trade Agreement

Rediff.com7 Aug 2026

A Parliamentary Standing Committee on Commerce has urged the Indian government to swiftly conclude the proposed India-US Bilateral Trade Agreement (BTA), while ensuring India's interests are protected, recommending complete exemption for key export products like generic medicines and smartphones from future US tariff increases.

Cipla Q1 net profit drops 39% to Rs 785.55 crore, North America sales down

Cipla Q1 net profit drops 39% to Rs 785.55 crore, North America sales down

Rediff.com23 Jul 2026

Homegrown pharma major Cipla Ltd reported a 39 per cent decline in consolidated net profit to Rs 785.55 crore in the first quarter ended June 2026, primarily due to a dip in sales in the North American market and higher expenses.

Is Pharmaceutical Engg Better Than BPham And PharmD?

Is Pharmaceutical Engg Better Than BPham And PharmD?

Rediff.com11 Nov 2025

rediffGURU Nayagam PP advises young aspirants how to pick the right course and career.

Why India Is Central To Rockwell Automation's Global Growth Plans

Why India Is Central To Rockwell Automation's Global Growth Plans

Rediff.com15 Jul 2026

Rockwell Automation's CEO Blake Moret highlights India as the centrepiece of the company's Asian growth strategy, detailing its four-decade presence, significant employee base, and support for the 'Make in India' initiative. The company sees major opportunities in pharmaceuticals, automotive, food and beverage, and consumer products, with AI playing a crucial role in simplifying industrial automation and boosting productivity for Indian manufacturers, including MSMEs.

Outbound M&A by Indian firms robust despite West Asia tensions: HSBC's Sharma

Outbound M&A by Indian firms robust despite West Asia tensions: HSBC's Sharma

Rediff.com10 Jul 2026

Indian companies' overseas expansion plans are holding strong despite geopolitical tensions in West Asia, driven by structural factors like supply-chain diversification, free trade agreements, and market expansion, according to Ajay Sharma, managing director and head of banking at HSBC India.